These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32051101)

  • 1. Re: Efficacy of Cannabidiol in Subjects with Refractory Epilepsy Relative to Concomitant Use of Clobazam.
    Mandelbaum DE
    Epilepsy Res; 2022 Feb; 180():106285. PubMed ID: 32051101
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam.
    Savage TE; Sourbron J; Bruno PL; Skirvin LA; Wolper ES; Anagnos CJ; Thiele EA
    Epilepsy Res; 2020 Feb; 160():106263. PubMed ID: 31923763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.
    Patel S; Grinspoon R; Fleming B; Skirvin LA; Wade C; Wolper E; Bruno PL; Thiele EA
    Epilepsia; 2021 Jul; 62(7):1594-1603. PubMed ID: 34050682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of cannabidiol in refractory epilepsy.
    Schaiquevich P; Riva N; Maldonado C; Vázquez M; Cáceres-Guido P
    Farm Hosp; 2020 Jun; 44(5):222-229. PubMed ID: 32853128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol efficacy and clobazam coadministration: Where do we stand now?
    Lattanzi S; Brigo F; Trinka E
    Epilepsia; 2020 Aug; 61(8):1795-1796. PubMed ID: 32662877
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trial simulations of the interaction between cannabidiol and clobazam and effect on drop-seizure frequency.
    Bergmann KR; Broekhuizen K; Groeneveld GJ
    Br J Clin Pharmacol; 2020 Feb; 86(2):380-385. PubMed ID: 31657863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol for Epilepsy: New Hope on the Horizon?
    Sanmartin PE; Detyniecki K
    Clin Ther; 2018 Sep; 40(9):1438-1441. PubMed ID: 30150078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol.
    Villanueva V; Carreño-Martínez M; Gil Nagel-Rein A; López-González FJ
    Rev Neurol; 2021 Apr; 72(S01):S1-S10. PubMed ID: 33908026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
    Hess EJ; Moody KA; Geffrey AL; Pollack SF; Skirvin LA; Bruno PL; Paolini JL; Thiele EA
    Epilepsia; 2016 Oct; 57(10):1617-1624. PubMed ID: 27696387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures.
    Klein P; Tolbert D; Gidal BE
    Epilepsy Behav; 2019 Oct; 99():106459. PubMed ID: 31519475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V; Reddy DS
    Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic synergism contributes to the antiseizure action of cannabidiol and clobazam.
    Rana RR; Rajasekaran K; Knappertz V; Gray RA
    Exp Neurol; 2023 Feb; 360():114286. PubMed ID: 36442674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerance of cannabidiol in the treatment of epilepsy in patients with Rett syndrome.
    Desnous B; Beretti T; Muller N; Neveu J; Villeneuve N; Lépine A; Daquin G; Milh M
    Epilepsia Open; 2024 Feb; 9(1):397-403. PubMed ID: 37485779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome.
    Kaplan EH; Offermann EA; Sievers JW; Comi AM
    Pediatr Neurol; 2017 Jun; 71():18-23.e2. PubMed ID: 28454984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of cannabidiol for seizure control in a patient with recurrent glioma.
    Hsu K; Whitham E; Kichenadasse G
    J Clin Neurosci; 2020 Jan; 71():275-276. PubMed ID: 31848037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol for treatment of refractory childhood epilepsies: Experience from a single tertiary epilepsy center in Slovenia.
    Neubauer D; Perković Benedik M; Osredkar D
    Epilepsy Behav; 2018 Apr; 81():79-85. PubMed ID: 29526578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol treatment of severe refractory epilepsy in children and young adults.
    Zilmer M; Olofsson K
    Dan Med J; 2021 Apr; 68(5):. PubMed ID: 33913416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clobazam higher-evening differential dosing as an add-on therapy in refractory epilepsy.
    Thome-Souza S; Klehm J; Jackson M; Kadish NE; Manganaro S; Fernández IS; Loddenkemper T
    Seizure; 2016 Aug; 40():1-6. PubMed ID: 27281712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.